Advanced Search

 

Study ID Status Title Patient Level Data
207323 Active, not recruiting Burden of illness among patients with eosinophilic severe COPD
207347 Not yet recruiting Persistence of immune response to GSK Biologicals’ HPV vaccine in healthy Chinese female subjects from the HPV-058 study
207348 Completed Meta-analysis of studies MEA112997 and MEA115588 of mepolizumab (SB240563) in severe asthma – additional subgroup analyses of exacerbations and investigation of relationship of FEV1 to exacerbations (eTrack Study Identifier 207348)
207350 Not yet recruiting A prospective, multi-centre post marketing surveillance (PMS) cohort study to monitor the safety of GlaxoSmithKline (GSK) Biologicals’ Human papillomavirus (HPV)-16/18 L1 VLP AS04 vaccine in female Chinese subjects aged between 9 and 25 years, when administered according to the Prescribing Information (PI) as per routine practice
207351 Active, not recruiting Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Albiglutide during Pregnancy
207387 Completed PGx7665: Exploratory Pharmacogenetic analysis of response to GSK2269557, a PI3 kinase delta inhibitor in patients from study 116678 with COPD
207388 Active, not recruiting PGx7666: Exploratory pharmacogenetic investigation of efficacy response to advair in COPD studies 116135, 116136, 111117, 114930, 114951, 116134, 112352, 113107, 113109, 116974
207389 Recruiting PGx7667 (207389) Exploratory Pharmacogenetic Investigation of Efficacy Response to mepolizumab in Eosinophilic Granulomatosis Polyangiitis (Churg-Strauss Syndrome) study 115921
207390 Not yet recruiting PGx7669: an exploratory pharmacogenetic efficacy investigation of steroid reduction in subjects with severe asthma treated with mepolizumab in 115575 and 115661
207440 Recruiting A Phase I, First Time in Human, Two Part, Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblind), Single and Repeat Dose Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK3352589, a REarranged during Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers
207449 Active, Not Recruiting Ulcerative Colitis and Crohn’s Disease: Resource Utilization and costs after initiation of biologics
207451 Completed A Proof of Concept (POC) Clinical Study to Investigate the Effects of a Developmental Cosmetic Moisturising Cream on the Barrier Function of Human Skin on the Face and Forearm
207467 Not yet recruiting Immunogenicity, reactogenicity and safety study of different formulations of GSK Biologicals' Meningococcal ACWY conjugate vaccine (GSK3536820A and Menveo) when administered to healthy adolescents and young adults 10 to 40 years of age
207468 Completed A Proof of Concept (POC) Clinical Study to Evaluate the Appearance of Fine Lines and Wrinkles on a Developmental Cosmetic Moisturising Cream in Healthy Subjects Presenting Visible Signs of Ageing
207478 Not yet recruiting Meta-Analysis Plan for GSK sponsored studies MEA117113 and MEA117106 of Mepolizumab (SB240563) in COPD – Analysis to assess effect of mepolizumab on rate of exacerbations requiring an emergency department visit or hospitalization and rate of severe exacerbations (eTrack Study Identifier 207478)
207488 Not yet recruiting Effects of oral ambrisentan on echocardiographic measures of right ventricular structure and function in Chinese patients with pulmonary arterial hypertension
207489 Recruiting An observer-blind study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals’ investigational vaccine GSK3277511A when administered to COPD patients
207521 Completed PGx7673: Confirmatory Genetics Reporting and Analysis Plan: Efficacy pharmacogenetic analysis of SLE patients treated with Benlysta in study BEL113750 (eTrack Study ID 207521)
207523 Completed PGx7664: Exploratory PGx evaluation of ALT elevations observed in subjects treated with GSK2881078 (SARM) from study 204699
207524 Active, Not Recruiting Quantitative Testing of Prescriber Knowledge about TANZEUMTM (albiglutide) Safety and Use Information
207531 Not yet recruiting The Extended Salford Lung Study (“Ex-SLS”) Data Access Project
207539 Withdrawn A Randomized, Double-Blind, Vehicle-Controlled, 3-Period, Sequential Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Repeat Topical Applications of GSK2894512 Cream in Healthy Adult Participants
207543 Recruiting Reactogenicity, safety and immunogenicity study of GlaxoSmithKline (GSK) Biologicals’ investigational supra-seasonal universal influenza vaccines - inactivated (SUIVs) (GSK3816302A) in healthy adults
207545 Completed A Bite Force Study Assessing Two Currently Marketed Denture Adhesive Products Compared to No-Adhesive Control.
207546 Not yet recruiting A randomised, double-blind (sponsor open), placebo-controlled, three part study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single (in both fed and fasted states) or repeat doses of GSK3358699 in healthy male participants

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.